The human b12 IgG1, specific for the CD4 binding site of the gp120 of HIV-1, was prepared by recombinant DNA technology. It had a high neutralization rate constant (03.5 1 10 5 M 01 sec 01 ), although this is about 10-fold less than the values for the best poliovirus or influenza A virus MAbs. The recombinant b12 Fab neutralized well, with about one-tenth of the activity of b12 IgG. The mechanisms by which b12 IgG1 and its Fab neutralize HIV-1 IIIB on C8166 cells have been investigated. Neither inhibited attachment of virus to the target cell as judged by FACS, immunofluorescence, and ELISA data. This was controlled using MAb F105, another human IgG1, that did neutralize by inhibiting attachment under our conditions. The interactions of b12 IgG-and Fab-neutralized virions with target cells were compared with those of nonneutralized virus using a number of different techniques (fluorescence dequenching of R18-labeled virions, immunofluorescence of virion gp41 and p24 antigens, and acquisition of resistance to removal of virions from the cell by protease). These and the inhibition of HIV-1-mediated cell-cell fusion all demonstrated that b12 IgG neutralized by inhibiting the primary fusionuncoating mechanism. However, the interactions of b12 Fab-neutralized and nonneutralized virions with C8166 cells were indistinguishable. Thus b12 Fab did not inhibit fusion uncoating, and by inference inhibited a stage of infection that occurs after the entry of the virion core into the cytoplasm. It is therefore possible that b12 IgG kills HIV-1 twice over, by fusioninhibition and by inhibiting the postentry event proposed for the Fab. The mechanism of neutralization of b12 Fab and of other MAbs that neutralize in a similar way and why b12 Fab and IgG neutralize by different mechanisms are discussed.
INTRODUCTION
per virion) can also determine the mechanism of neutralization. Other factors, such as multivalent binding of antiNeutralization is an in vitro phenomenon, in which neubody to virion, depend both on properties of the virion tralizing antibody binds to the surface of a virus particle (epitopes spaced neither too close together nor too far and causes loss of infectivity (Dimmock, 1993 (Dimmock, , 1995 . The apart) and of the neutralizing antibody (molecular interacepitope involved is usually protein but can be carbohytions of epitope and paratope such that one arm of a drate. Nonneutralizing antibodies also exist, which imbivalent antibody is oriented away from the virion). The plies that neutralization results from the binding of antisituation is made more complex because any of the pabody to a specific site on the virion. Neutralization can rameters mentioned may operate in combination. Finally also be indirect and can result, for example when antithe host and the target cell can determine qualitatively bodies bind complement components. Thus nonneuor quantitatively the extent of neutralization (Dimmock, tralizing antibodies can become neutralizing, and neu-1993, 1995; Sawyer et al., 1994) . tralizing antibodies can neutralize both indirectly and di-
The commonly regarded mechanism of neutralization rectly.
by steric inhibition of the interaction between virus and There are many mechanisms by which antibodies can its cell receptor occurs only rarely, and a direct quantitadirectly neutralize virus infectivity, and any one virus can tive relationship has been established for only a few be neutralized in a variety of different ways depending virus-IgG monoclonal antibody (MAb) combinations (e.g., on a number of variables. Viruses have several antigenic Newcastle disease virus with some but not all of its (neutralization) sites, each consisting of a number of epiMAbs, Iorio et al., 1989 ; rhinovirus type 14 with MAb 17-topes, and these may be present on one or more surface 1A, Smith et al., 1993 ; Table 1 of Dimmock, 1993) . At high proteins. It is likely that the mechanism of neutralization concentration the larger polymeric antibodies, IgA and will be influenced by the functional role of the domain IgM, inhibit attachment by binding to the virion by one recognized by antibody. In addition, properties of the antiof their immunoglobulin units and projecting radially from body (e.g., paratope, isotype, number of molecules bound the surface of the virion. At lower concentrations they bind multivalently and are no more able to inhibit attachment than IgG (Dimmock, 1993) . Usually neutralizing anti-tachment, such as primary uncoating by fusion or other including isolates which were resistant to neutralization by pooled human sera from HIV-infected patients (Burton means, and postprimary uncoating events.
Many neutralizing MAbs to HIV-1 have been described. et al., 1994) . Here we find that b12 IgG did not inhibit attachment of neutralized virus to the target cell, but inThe major neutralization sites on gp120 are located on the V3 loop and in the region of the CD4-binding site, hibited the fusion entry process in direct proportion to the extent of neutralization. Neutralizing amounts of b12 with minor sites on the V1/V2 loops. There is also at least one important site on the transmembrane gp41 (reFab inhibited neither attachment to, nor fusion entry of virus into the target cell and, by inference, inhibited a viewed by Moore and Ho, 1995; Sattentau and Moore, 1995) . There have been few studies of how anti-HIV-1 postentry stage of infection. antibodies neutralize (see reviews by Poignard et al., 1996; Sattentau, 1996) . Most of the ''CD4 binding site MATERIALS AND METHODS MAbs'' are defined by their ability to block attachment of Cells soluble recombinant (sr) gp120 to srCD4 but only a few have been tested for their ability to block attachment of The CD4 / human T cell lines, C8166 and H9 (MRC infectious virus to susceptible target cells. While some AIDS Reagent Project (ARP)), and the CD4 0 T cell line, human postinfection sera have been shown to block at-A2.01 (a kind gift of Dr Q Sattentau), were grown in RPMI tachment of HIV-1 to cells 1640 (Gibco-BRL Life Technologies, Paisley, UK) supal., 1988; Skinner et al., 1988; Montefiori et al., 1993) , few plemented with 10% heat inactivated fetal calf serum other antibodies appear to have this property. MAb F105 (HIFCS), glutamine (2 mM), penicillin (100 U/ml), and (Posner et al., 1991) , and some other binding site antibodstreptomycin (100 mg/ml). Stably transfected HeLa cells ies blocked attachment of virus to lymphoblastoid cells expressing the T4(CD4) protein (HeLa-T4(CD4), Maddon (H9 and C8166), but only F105 inhibited attachment in et al., 1986) were obtained from Dr. R Axel via the MRCproportion to its neutralizing activity. V3-specific MAbs ARP and grown in DMEM with 5% HIFCS, 4 mM glutado not inhibit the association of srgp120 and srCD4, and mine, and 1 mg/ml Geneticin (Gibco-BRL). the few which have been examined do not inhibit attachment of virus to cells (0.5b, 9284, Skinner et al., 1988; Virus BAT123, Sun et al., 1989; F58, ICR41.1i, Armstrong et al., HIV-1 IIIB was propagated by cocultivating chronically 1996). The HIV-1 genome enters cells by neutral pH fuinfected and uninfected H9 cells at a ratio of 1:4 for 72 sion of the viral and plasma membranes (Marsh and hr at 35Њ. Cells were placed in fresh medium 24 hr prior Pelchen-Matthews, 1993). Many V3-specific antibodies to harvesting to minimize the presence of free viral proinhibit HIV-1-mediated cell fusion, but only one study has teins, and tissue culture fluids (TCFs) were centrifuged shown that neutralization correlated quantitatively and to remove cells and debris. Infectivity was measured in directly with the inhibition of virus fusion entry into the C8166 cells immobilized to 96-well plates with poly-Lcell (Armstrong et al., 1996) . In the same study, another lysine after 3 days incubation at 35Њ by counting syncytia neutralizing V3-specific MAb, ICR41.1i, did not inhibit fu- (McLain and Dimmock, 1994) , or using nonanchored sion. Knowledge of how antibodies inactivate infectivity cells and incubating for 4 days at 35Њ, and scoring for is desirable in order to understand how they might be the presence of syncytia in an end-point assay. Nonbest employed in passive administration to prevent and/ virion-associated p24 was removed by gel filtration of or combat HIV-1 infection in vivo, and to determine the virus through Sephacryl S-1000 Superfine (Pharmacia Binature of antibodies that future vaccines should aim to otech AB, Uppsala, Sweden). Fractions (approximately stimulate. Antibodies can also be regarded as inhibitors 115 ml) were analyzed by ELISA for p24 (see below) and which allow investigation of the early processes of infecfor infectious virus. Figure 1 shows a typical elution protion, and knowledge of how they act may lead to the file. The majority (92%) of p24 protein coeluted with infecdevelopment of antivirals that mimic their mode of action. tious virus; this may be an underestimate since the OD Here we report an investigation of the mechanism by was near background for many fractions. These very low which a human recombinant IgG1 and Fab (Burton et al., levels of free p24 protein agree with previous reports 1991, 1994) neutralize HIV-1 strain IIIB. On the basis of (Moore et al., 1990; McKeating et al., 1991) . competition and mutagenesis studies the epitope of this MAb has been localized to a region of the CD4 binding Antibodies site (Barbas III et al., 1992 , 1993 Roben et al., 1994) . The Fab exhibited high neutralizing activity and cross-B12 Fab is a recombinant antibody produced by the phage display method from a combinatorial library preneutralized several strains of HIV-1, including a number of primary isolates (Barbas III et al., 1994; Roben et al., pared from the bone marrow of a long-term asymptomatic HIV-1 seropositive donor and identified by recogni-1994). Conversion of the Fab to IgG1 conferred upon it the ability to neutralize a much wider range of primary tion of srgp120 of HIV-1 IIIB. Fab was expressed in Escherichia coli (Burton et al., 1991) . The heavy chain gene virus isolates at reasonably low antibody concentration, FACS analysis to show the effect of neutralizing antibody on the attachment of virus to cells and demonstration that neutralized virus was attaching to CD4 receptors Fcg receptors were blocked with normal rat IgG as described above. Cells were washed and incubated with an anti-CD4 MAb Q4120 (40 mg/10 6 cells/ml; MRC-ARP; Healy et al., 1990) for 2 hr at 4Њ and then used without washing in attachment assays. Purified nonneutralized virus (2 1 10 4 sfu) or virus neutralized with b12 IgG were added to 10 6 cells and attachment was allowed to proceed for 2 hr at 4Њ. MAb F105 (human IgG1) which blocks attachment of neutralized HIV-1 to cells was used as a   FIG. 1 . Analysis of the p24 content of tissue culture supernatant from control (Posner et al., 1991 (Burton et al., 1994) . Recombinant antiFACStar, exciting at about 488 nm and measuring emitbodies were stored at 070Њ. All experiments (with the ted light of 515-545 nm via the fluorescence 1 channel. exception of the data in Fig. 8 ) used the same stock Both the anti-p24 antibody and the biotinylated antiof recombinant antibodies. However, some neutralizing sheep antibody were absorbed with methanol-fixed H9 activity was lost on storage so the specific neutralizing cells (which lack Fc receptors) prior to use. activity is seen to vary through the paper. Human IgG from HIV-1 seronegative donors was prepared by affinity
Immunofluorescence study of the attachment and chromatography using protein G-Sepharose (Gamentry of nonneutralized virus into HeLa-T4(CD4) cells, mabind Plus, Pharmacia Biotech AB, Uppsala, Sweden). and the effect of neutralizing b12 IgG and Fab Protein concentrations were determined spectrophotometrically or using a dye binding procedure (Bio-Rad Immunofluorescence was carried out as described by Laboratories, München, Germany). Armstrong et al. (1996) . Briefly we used HeLa-T4(CD4) cells since lymphoblastoid cells, such as C8166 cells, Kinetic neutralization assays have very little cytoplasm and are unsuitable for following the intracellular location of viral components after infecVirus (1.2 1 10 3 syncytium forming units per ml (sfu/ tion. Virus was concentrated using Centriprep 100 conml)), was mixed with a dilution of antibody and incubated centrators (Amicon, Stonehouse, UK) and stored over liqat 35Њ. At intervals an aliquot was removed and assayed uid nitrogen. Before use virus was passed through Sephby counting syncytia on monolayers of C8166 cells acryl S-1000 Superfine to remove free viral proteins. Then (McLain and Dimmock, 1994) . There was no loss of infec-2.5 1 10 4 sfu were added to 2 1 10 5 cells on 16-mmtivity of a virus control incubated without antibody. diameter coverslips which had been grown overnight in Assays were the mean of six replicates.
the absence of Geneticin. Based on our estimate of 3000 physical particles: 1 infectious unit (T. L. McInerney, unpublished data), the inoculum approximated to 300 physiBlocking of Fcg receptors on C8166 cells cal particles per cell. Twenty-five microliters of virus was incubated for 1 hr at 35Њ with an equal volume of IgG or To prevent the possibility of virus-IgG complexes attaching to Fcg receptors present on C8166 cells, we Fab that gave approximately 99% neutralization. This was then incubated with cells for 2 hr at room temperature. used 1 mg/ml of normal rat IgG (100 ml/10 6 cells) for 1 hr at 4Њ to saturate FcgRI receptors, and then with 10
Samples were washed to remove virus and either fixed immediately or incubated at 35Њ for 3 or 6 hr to permit mg/ml heat-complexed (65Њ, 30 min) normal rat IgG to saturate FcgRII and RIII receptors (McLain and Dimvirus internalization before fixing. Fixation consisted of 0.4% paraformaldehyde for 1 hr at 4Њ and 0.4% paraformmock, 1997). Cells were then washed once in cold medium and used in various assays described below. aldehyde overnight. Cells were then treated with 0.2% Empigen for 0.5 hr washed and stored at 020Њ. Nonspe-0). Fusion was measured by scoring syncytia (see below) under low power magnification. Fusion was allowed to cific binding of antibody etc. was prevented by blocking with 1% glycine and 5% sheep serum. Virion p24 was proceed in samples for a further 3 hr at 35Њ, then samples were fixed with 2% formaldehyde. Cells were viewed undetected using biotinylated sheep anti-p24 antibody (MRC-ARP), followed by streptavidin-fluorescein (Amerder low power microscopy, and those with a diameter at least twice that of a normal cell were considered to be sham Life Sciences), and gp41 with the human MAb 2F5 (Muster et al., 1993) and a monoclonal biotinylated the product of cell-cell fusion. Staining and counting showed that these contained 3 to 8 nuclei (mean Å 4.7 mouse anti-human IgG Fc (Sigma) followed by streptavidin-fluorescein. The latter did not detect cells with nuclei; data not shown). The number of fused cells occurring spontaneously in the nonincubated control was attached b12 Fab-neutralized virus, and very weakly with cells with attached b12 IgG-neutralized virus. Addition of subtracted. Over 1000 cells were counted for each sample. In three experiments, there was an average 0.9% anti-gp41 to the latter increased fluorescence many fold. Although the fluorescence was apparent to the eye, it syncytia in the unincubated controls and 5.7% in the incubated fused controls (data not shown). A total of approxiwas too weak to photograph, so the signal was amplified with a mouse anti-fluorescein MAb (Sigma), biotinylated mately 10 3 cells was counted from each sample and percentage fusion calculated as the number of syncytia/ sheep anti-mouse IgG, and streptavidin-fluorescein. Cells were examined and photographed under UV light total number of cells counted. The baseline number of syncytia was subtracted from both values. The effect of using a Zeiss Axioskop microscope. About 1000 cells per group were counted to quantitate the distribution of neutralizing b12 antibody on fusion was determined by adding serial dilutions to infected cells (2 1 10 4 infected fluorescence.
cells/100 ml antibody dilution) for 1 hr at 35Њ and then Fusion of HIV-1 virions with cells as measured by proceeding as described above. Neutralization assays R18 fluorescence dequenching and the effect of were carried out in parallel using the same antibody neutralizing antibody dilutions as for the fusion experiments. Antibody dilutions and virus (700 sfu) were incubated together for 1 hr and Virus was purified by ultracentrifugation and incubated then incubated for a further 3 hr at 35Њ with 1.4 1 10 5 in 500 ml of 630 mM octadecyl rhodamine B chloride (R18: C8166 cells. Free antibody and unattached virus were Molecular Probes Europe BV, Leiden, The Netherlands) removed by centrifugation, cells dispensed, and neutralprepared by diluting an ethanolic solution of R18 1/100 ization determined after 3 days incubation at 35Њ. in PBS for 1 hr at room temperature in darkness to allow R18 to dissolve in the lipid bilayer of the virion. Free R18
Detection of viral capsid protein p24 in cell lysates was removed by pelleting virus over 20% sucrose. R18-Sheep antiserum to HIV-1 p24 (D7320; Aalto Biorealabeled virus lost no infectivity during these procedures.
gents, Dublin, Eire) was bound to wells of ELISA plates In agreement with others (Hoekstra et al., 1984; (Immulon 2; Dynatech Laboratories, Billingshurst, UK) by et al., 1988) we found that solubilization of virus in Triton incubating 1 mg/well in 100 mM NaHCO 3 , pH 8.5, at room X-100 led to ú100-fold increase in fluorescence, sugtemperature overnight. After washing with Tris-buffered gesting that the R18 was highly self-quenched and incorsaline (TBS; 0.14 M NaCl, 0.02 M Tris buffer, pH 7.6), porated in the virus lipid bilayer. R18-labeled HIV-1 or nonspecific binding sites were blocked with 2% milk proneutralized (1 hr at 35Њ) R18 labeled HIV-1 (1 1 10 5 sfu) tein (Marvel; Premier Beverages). In order to assay cellwas mixed with 5 1 10 6 C8166 or A2.01 cells (a CD4-associated virion p24 protein, cell pellets were lysed by negative T cell line) and incubated at 35Њ. At intervals, suspending in 600 ml of 1% Empigen detergent in PBS aliquots of 1 1 10 6 cells were removed, washed with at 56Њ for 30 min. Cell lysates (100 ml) were added to PBS, and a sample was taken to determine the amount wells and plates held at room temperature overnight. of neutralization. The remainder were fixed with 2% paraRecombinant p24 (MRC ARP) was included as a standard formaldehyde. Fluorescence was determined using a when required. Wells were washed with TBS containing Becton-Dickinson FACStar, exciting at about 488 nm 0.05% Tween (TBST) and a biotinylated mouse anti-p24 and measuring emitted light of 560-590 nm via the fluoMAb added (100 ml/well; 1/1000 in TBST; MRC-ARP). rescence 2 channel. Virus was used within a few days
Plates were held for another 2 hr, then wells were of labeling.
washed and streptavidin-alkaline phosphatase was added (Amersham, UK). One hour later, this was re-HIV-1-induced cell fusion and the effect of moved, wells were washed, and substrate was added neutralizing antibody [p-nitrophenyl phosphate, 1 mg/ml (Sigma, UK) in 9.7% diethanolamine, 0.5 M magnesium chloride, pH 9.8 C8166 cells were infected with HIV-1 (0.01 sfu/cell) and incubated for 3 days at 35Њ. These cells (2 1 10   4   ) (Pierce, Rockford, IL)]. Plates were incubated at 35Њ in the dark and then the optical density was measured at were then added to noninfected C8166 cells (2 1 10 5 ) and the baseline level of cell-cell fusion determined (time Å 405 nm.
Attachment of virus to C8166 target cells and the effect of neutralizing antibody
HIV-1 (2 1 10 4 sfu) was added to 10 6 C8166 target cells and incubated for 2 hr at 35Њ to allow virus to attach to cell receptors. Unattached virus was removed by centrifugation and cell pellets were washed several times with phosphate-buffered saline (PBS). Cells were lysed with 1% Empigen detergent (Calbiochem, Nottingham, UK) and attachment of virions determined by p24 ELISA. In order to determine the effect of b12 Fab or IgG on the attachment of virus to cells, dilutions of antibody (400 ml) were preincubated with virus (2 1 10 4 sfu/400 ml) for 1 hr at 35Њ prior to the addition of cells. All subsequent steps were as described above. The amount of neutral- 
Removal of HIV-1 attached to C8166 cells by trypsin
We used the method of Krust et al. (1993) , except that that bivalency and hence cross-linking of virus particles HIV-1 (4 1 10 4 sfu) or neutralized HIV-1 was added to or individual gp120 monomers is not required for neutral-C8166 cells (2 1 10 6 ) for 2 hr at room temperature. These ization with this particular antibody. conditions allowed attachment of virus to cells with mini-
(ii) Kinetics of neutralization. Kinetic neutralization mal fusion (Armstrong et al., 1996) . Nonattached virus assays were carried out to determine the order of reacand antibody were then removed by centrifugation. Cells tion and the neutralization rate constant of b12 IgG and were then resuspended in 1 ml fresh medium and incuFab (Fig. 3) . Note that about 10-fold more Fab than IgG bated for a further 3 hr at 35Њ to allow fusion of virus and was used in Fig. 3 . The neutralization rate constant 0k, cell membranes. Cells were washed once in medium was calculated using the expression: without serum and divided into two aliquots: one was treated with 200 ml of trypsin (1.3 mg/ml; Difco Laboralog 10 V t /V 0 Å (0k/2.3D).t tories, Detroit, MI) at room temperature for 10 min to where V 0 and V t are the infectivity at times 0 and t, remove any virus attached to the outside of the cells, respectively, and D is the molar concentration of antiand the other was incubated with RPMI to measure the body (Mandel, 1985) . Neutralization rate constants for total amount of cell-associated virus. One milliliter of the data in Fig. 3 3.5 { 0.5 1 10 5 for IgG and 3.7 { 0.5 1 10 4 for b12 Trypsin routinely removed ú90% virus attached to the Fab. B12 IgG and Fab both neutralized without a signifisurface of the cell. Data were corrected for the small cant lag period showing that loss of infectivity profraction of virus which was not removed by treatment ceeded by pseudo-first order kinetics. with trypsin. IgG from seronegative human donors was included as a negative control for neutralization. The ex-B12 IgG does not inhibit the attachment of tent of neutralization was determined by removing an neutralized virus to C8166 cells, and IgG-neutralized aliquot of virus-inoculated cells following the first wash virus attaches via CD4 receptors and culturing these for 3 days (2 1 10 4 cells/well) at 35Њ before counting syncytia.
One mechanism by which antibody mediates neutralization of viral infectivity is by blocking attachment of the RESULTS virus particle to its specific cell receptor. As the epitope of b12 has been mapped to the CD4 binding site on Properties of b12 IgG and Fab srgp120 (Barbas III et al., 1992 , 1993 Roben et al., 1994) such a mechanism would not be unexpected. As a con-(i) Neutralization of HIV-1. B12 IgG and Fab both neutralized HIV-1 well (Fig. 2) . On a molar basis the IgG was trol, we determined the effect on virus attachment of MAb F105, another human IgG1 CD4-binding site-specific approximately 10-fold more efficient than Fab, with 50% neutralization at 0.3 and 2.5 nM (or 0.05 and 0.13 mg/ml),
MAb like b12, that neutralizes by inhibiting attachment to the target cell (Posner et al., 1991) . However, before respectively. The ability of Fab to neutralize indicates b12 concentration threefold gave 96% neutralization and over 70% virions attached to cells. In addition the attachment of HIV-1 neutralized by Fab b12 to 98% to C8166 cells was not inhibited. Saturation of FcgRs with monomeric and complexed IgG had no effect on the attachment of b12 IgG-or Fab-neutralized virus (data not shown).
From the data above we conclude that b12 IgG and Fab do not neutralize by inhibiting attachment to the target cell, and that HIV-1 neutralized by these antibodies attaches to the same domain of the CD4 receptor as   FIG. 3 . Kinetics of neutralization of HIV-1 with b12 IgG () and b12 Fab (ᮀ) on C8166 cells. Virus (1.2 1 10 3 SFU/ml) was incubated with 1.3 nM IgG or 10 nM Fab at 35Њ for the indicated times. Infectivity was determined by counting syncytia after incubation. V t /V 0 is the ratio between infectivity at time t and that observed in the absence of antibody (time 0). There was no loss of infectivity when virus was incubated alone under the same conditions. Neutralization rate constants (0k) for the data shown were IgG: 3. Figure 4 IgG1 MAb, b12. Cellular Fcg receptors were first blocked as described shows that MAb Q4120 completely inhibited attachment above and virus (2 1 10 4 SFU) incubated with b12 IgG as described below. Virus-antibody mixtures were inoculated onto C8166 cells or of nonneutralized virus (Fig. 4C, solid line) , and of virus cells treated with the Q4120 anti-CD4 MAb in order to demonstrate neutralized by b12 IgG (Figs. 4D and 4E , solid line), giving specificity of attachment. Attachment was then allowed to proceed for a very similar trace to that of the noninoculated cell con-2 hr at 4Њ. The presence of cell-associated virus and neutralization were trol (Fig. 4C, broken line) . Thus b12 IgG does not inhibit (10 6 ) were added and virus allowed to attach for 2 hr at 35Њ. Cells were then washed with PBS and cell pellets were lysed with 1% Empigen detergent. Virus attached to cells was detected by p24 ELISA. Neutralization was determined by culturing a sample of cells removed from mixtures before the washing procedure and counting syncytia after 3 days incubation at 35Њ. Attachment (bars) is expressed as the percentage of virus bound in the presence and absence of antibody and is compared with neutralization (ଙ). Normal human IgG did not neutralize and did not affect attachment of virus to cells (data not shown).
does infectious virus. These experiments were controlled that this antibody inhibited the fusion-uncoating process even though it did not inhibit attachment (see above). In by the demonstration that, under the same conditions, this experiment IgG b12 neutralized by 98.6%. In contrast, MAb F105 IgG neutralized by inhibiting attachment of virus neutralized by b12 Fab to almost the extent (94.1%; virus to cells. Inhibition of virus attachment by F105 also Fig. 6D ) showed an increase in fluorescence that paralverified that we were detecting virions with our anti-p24, leled that of the nonneutralized control. rather than nonvirion p24 protein. In fact this was not a problem as there was very little nonvirion p24 in the virus Neutralizing b12 IgG, but not b12 Fab, inhibits HIV-1-preparation (Fig. 1) , and srp24 did not bind to C8166 cells mediated cell-cell fusion when added under conditions of virus infection (data not In order to confirm and extend data on virion-cell fushown). Possible reasons why one human IgG1 CD4 sion, the ability of b12 IgG and Fab to inhibit HIV-infected binding site MAb (F105) inhibits attachment of neutralcell-cell fusion was quantitated. Infected and noninized virus to cells and another (b12) does not are disfected C8166 cells were incubated together in the prescussed later.
ence of various amounts of neutralizing b12 IgG or Fab. IgG b12 reduced infectivity and fusion in parallel, with Measurement of fluorescence dequenching shows 0.3 mg/ml IgG giving over 95% neutralization and 70% that neutralizing b12 IgG, but not b12 Fab, inhibits the inhibition of fusion (Fig. 7) . Increasing the antibody confusion of HIV-1 virions to C8166 cells centration 20-fold to 6.3 mg/ml increased neutralization to over 99% and reduced fusion activity by 90%. In contrast Nonneutralized R18-labeled virus was incubated at 35Њ enough Fab (20 mg/ml) to effect 92% neutralization rewith C8166 cells and samples were taken at 0, 1, 2, and duced the fusion activity by only 30%, while increasing 3 hr. Figure 6A shows fluorescence dequenching took the Fab concentration by threefold gave 99% neutralizaplace up to 3 hr, indicating that fusion was occurring over tion but no further reduction in fusion (Fig. 7) . A F(ab) 2 this period. Three hours incubation gave the maximum derived from b12 IgG by digestion with pepsin behaved fluorescence. Such a relatively slow fusion process was exactly like the IgG in inhibiting fusion (data not shown). consistent with our other observations of virus entry (see Clearly b12 IgG inhibited HIV-1-mediated fusion, while below) and those of others, but at odds with another R18 b12 Fab did not. These and the foregoing data also indistudy in which fusion between HIV-1 (strain NIT) and cate that b12 IgG inhibits both HIV-1 virion-cell and HIV-CEM cells reached a maximum in 10 min (Sinangil et al., 1-mediated cell-cell fusion to a similar extent.
1988). As a control, R18-labeled virus was incubated with
Immunofluorescence analysis shows that neutralizing the CD4 0 A2.01 T cells, to which virus would be unable b12 IgG but not Fab inhibits internalisation of HIV-1 to attach specifically, and no increase of fluorescence by HeLa-T4(CD4) cells was observed (Fig. 6B) . Incubation of virus neutralized by b12 IgG with C8166 cells showed very little increase HeLa-T4(CD4) cells were used for immunofluorescence studies since T lymphoblastoid cells, like the in fluorescence and thus fusion (Fig. 6C) , demonstrating C8166 cell line, have insufficient cytoplasm to allow resob12 IgG attached to cells in amounts indistinguishable from nonneutralized virus. However, this pattern of surlution of the intracellular distribution of viral proteins. Neutralization of HIV-1 in HeLa-T4(CD4) cells was reface fluorescence did not change after incubation at 35Њ for 3 hr (Fig. 8f) , and by 6 hr had decreased in intensity quantitated, and the entry of virus followed using antip24 and anti-gp41 antibodies (Fig. 8) . Although the cyto- (Fig. 8g) . Initially the same amounts of cell surface gp41 were present as in the nonneutralized control cells (data plasm of the HeLa-T4(CD4) cells was never as well spread as in nontransfected HeLa cells, the major cell not shown), but by 3 hr this was barely detectable (Fig.  8h) , whereas there was no loss of staining in the nonneustructures could be clearly seen. Anti-p24 antibody staining of nonneutralized virus attached to cells at room temtralized control (Fig. 8d) . These data are consistent with the conclusion that b12 IgG did not inhibit attachment of perature (0 hr) showed diffuse fluorescence over the cell surface (Fig. 8a) . In all, 97% infected cells showed this neutralized virus to cells, but inhibited the fusion-entry process. This agrees completely with the direct measurecharacteristic fluorescence, compared with only 2% of noninfected cells (Fig. 8m) . Following incubation at 35Њ ment of b12 IgG-inhibition of fusion shown above in Figs. 6 and 7. The coordinate loss of gp41 and p24 is probably for 3 and 6 hr, the distribution of virion p24 changed completely with antigen migrating into the cytoplasm and due to the slow elution of attached virus from the cell surface. perinuclear region (Figs. 8b and 8c) . In contrast, gp41 remained on the cell surface although with some aggreIn contrast virus that was neutralized by b12 Fab by 99.3% showed the same pattern of immunostaining of gation (Fig. 8d) . Noninfected cells reacted with anti-gp41 antibody did not stain (Fig. 8n) . These data are consistent virion p24 and gp41 as nonneutralized virus (compare Figs. 8i-l with 8a-d). Note that after incubation at 35Њ with the accepted view that HIV-1 infects cells by the fusion of the viral and plasma membranes, with the subthe patterns of staining with anti-p24 (Figs. 8j and 8k ) and with anti-gp41 antibodies (Fig. 8l) no longer corresequent entry of the virion core (virion RNA, p24, and other proteins) into the cytoplasm.
sponded. Thus these data are consistent with the interpretation that b12 Fab did not inhibit attachment of virus Figure 8e confirms that virus neutralized by 99.6% by FIG. 7 . B12 IgG inhibited HIV-1-mediated cell-cell fusion, while b12 Fab did not. Aliquots of infected cells were incubated with increasing concentrations of antibody for 1 hr prior to the addition of noninfected C8166 cells at a ratio of 1:10. Cells were fixed after 3 hr incubation at 35Њ, aliquots removed, and the percentage fusion (hatched bars) was determined by counting syncytia. Approximately 10 3 cells were counted from each sample. The baseline level of fusion in a sample incubated without antibody was measured immediately following mixing of the cells (i.e., time 0) and results corrected for this value. Fusion observed in samples incubated in the presence of antibody are expressed as a percentage of fusion measured in a control incubated without antibody. Neutralizing activity (ଙ) was determined using the same antibody dilutions. Nonimmune human IgG did not neutralize or inhibit cell fusion (solid bar).
to the cell and did not inhibit the fusion of viral and of removal of HIV-1 from cells by trypsin, and this paralleled the neutralization of infectivity. These quantitative cellular membranes. The fact that the staining of virion p24 and gp41 was not coordinated after incubation at data are consistent with the view that resistance to trypsin reflects fusion entry of virus and that b12 IgG inhibits 35Њ is consistent with a fusion mechanism of virus entry and does not support the view that virus entered the cell the fusion-entry process of HIV-1 but b12 Fab does not. by endocytosis. These data are all in accord with the failure of b12 Fab to inhibit HIV-1-mediated virion-cell DISCUSSION and cell-cell fusion (Figs. 6 and 7) .
Here we have investigated the mechanisms of neutralQuantitation based on counts of approximately 1000 ization of HIV-1 IIIB by b12, a human IgG1 and b12 Fab cells was carried out on cells immunostained for p24 that recognizes an epitope in the region of the CD4-and supported the above conclusions. At 3 hr postinfecbinding site of gp120. Both b12 IgG1 and Fab neutralized tion, 96% cells inoculated with nonneutralized virus efficiently, with the IgG having a 10-fold higher specific showed the cytoplasmic pattern of fluorescence deactivity than b12 Fab both on a molar basis and acscribed above, while 12% still had the diffuse fluorescording to their neutralization rate constants. However, cence of virus attached to but not fused with the cell even though b12 is one of the most active HIV-1-neusurface. The data for cells inoculated with b12 Fab-neutralizing antibodies yet described, its neutralization rate tralized virus were in close agreement with 90% cytoconstant is only around 10% of the constants of the best plasmic and 9% surface fluorescence. However, cells poliovirus and influenza virus IgG MAbs (Icenogle et al., inoculated with b12 IgG-neutralized virus were in com-1983; McLain and Dimmock, 1994 ; D. J. Schofield and plete contrast with 1% having cytoplasmic fluorescence N. J. Dimmock, unpublished data). Taken at face value, and 97% with the original diffuse surface pattern.
this means that the maximum protective efficiency of HIV-1 neutralizing antibodies in vivo is unlikely to be Nonneutralized HIV-1 and virus neutralized with b12 attained until antibodies with a neutralizing activity inFab become resistant to removal from C8166 cells by creased by about 10-fold can be obtained. However, neutrypsin, while virus neutralized by b12 IgG does not tralization rate constants vary with both viral isolate and target cell (Dimmock, 1993) and our data obtained with Nearly all nonneutralized virus that attached to cells at 4Њ can be removed by treatment with trypsin, as demlaboratory-adapted virus and a T cell line may prove to be an over-estimate compared to those expected with onstrated by ELISA or by immunofluorescence (data not shown). However, on incubation at 35Њ, virus became primary virus isolates and primary cells. Neutralization with both IgG1 and Fab followed progressively resistant to such treatment. Representative data in Fig. 9 show that HIV-1 treated with b12 Fab also pseudo-first order (single-hit) kinetics. In terms of protective immunity this would seem to be an advantage over became resistant to removal by trypsin from C8166 cells. In contrast, b12 IgG completely inhibited the acquisition other MAbs which have multi-hit kinetics and neutralize 322 FIG. 9. B12 IgG inhibited the acquisition of resistance to removal of HIV-1 from C8166 cells by incubation with trypsin, while b12 Fab did not. Virus was preincubated with dilutions of antibody and then allowed to attach to C8166 cells for 2 hr at room temperature. There is no appreciable virus-cell fusion under these conditions. Nonattached virus was removed by washing and cells incubated for a further 3 hr at 35Њ. One-half of the cell suspension was then treated with trypsin to remove attached virus and the other half mock-digested to give the total cell-associated virus. Both were lysed with Empigen and virion p24 measured by ELISA. Virus resistant to trypsin treatment (hatched bars) is expressed as a percentage of the nonneutralized virus control and is compared with the amount of neutralization (ଙ). Normal human IgG did not neutralize or affect resistance to trypsin (solid bar). Neutralization was determined by culturing aliquots of cells after nonattached virus had been removed by washing.
with a delay of up to 15 min (McLain and Dimmock, 1994) . srgp120 to srCD4 and was affected by mutations in amino acids which are known to contribute to binding The interpretation of the order of reaction in terms of the number of molecules of antibody per virion required for site activity (Barbas III et al., 1992; Roben et al., 1994 ). An explanation may be that inhibition by b12 Fab of the neutralization is uncertain (Dimmock, 1993) . If it means that one molecule of antibody per virion is required, there binding of one monomer of srgp120 to srCD4 requires a 1:1 stoichiometry, whereas neutralization can be effected is a problem in explaining how a virus like HIV-1 can be neutralized since HIV-1 has 225 or 300 molecules of by a number of antibody molecules per virion which is far from saturating (for examples, see Dimmock, 1993) . gp120 [assuming there are 75 envelope spike proteins (Gelderblom et al., 1987) and that each is a trimer (as Failure of b12 IgG and Fab to inhibit attachment of neutralized virus to cells is in accord with their single-hit suggested by the trimerisation of the MA (p17) protein; Hill et al., 1996) or a tetramer (Pinter et al., 1989; Scha- kinetics of neutralization (Fig. 3) , since neutralization by inhibition of attachment requires inhibition of at least waller et al., 1989) ]. Alternatively the kinetic neutralization curves in Fig. 3 can be explained by fractional neutralizaseveral ligand-receptor interactions that would inevitably have multi-hit kinetics (for example, by MAb F105 or tion, whereby each of x bound antibody molecules reduces infectivity by 1/x-fold (Icenogle et al., 1983) . sCD4: L. McLain and N. J. Dimmock, unpublished data). The above and other data on HIV-1 (Lasky et al., 1987 Our data on the mechanism of neutralization show that HIV-1 neutralized by b12 IgG1 attached to C8166 cells and personal communication; Schnittman et al., 1988) and rabies virus (Bracci et al., 1988; Cusi et al., 1991) via the CD4 receptor, and that attachment of neutralized virus to cells was not inhibited (Figs. 4, 5, and 8 ). This was showing that antibodies which effectively block the monomer envelope protein-cell receptor interaction do controlled with MAb F105, another human IgG1, which clearly neutralized by inhibiting attachment of virus to not neutralize, suggesting that this assay has little relevance to the interaction of virus particles and cells in cells in our system and that of others (Figs. 4A and 4B; Posner et al., 1991) , and supported by the ability of b12 general and to neutralization in particular. The binding of b12 Fab, unlike other members of a panel of similarly IgG to neutralize virus after it had attached to cells (unpublished data). Failure of b12 to inhibit attachment might derived recombinant anti-HIV-1 MAbs, was significantly diminished by the deletion of the V1, V2, and, to a lesser seem surprising as it had been mapped to the CD4 binding site of gp120, through inhibiting binding of monomeric extent, V3 loops of gp120 (Roben et al., 1994) and sug-
Immunofluorescence analysis of the fate of the p24 and gp41 proteins of nonneutralized and neutralized HIV-1 virions (V) inoculated onto HeLa-T4(CD4) cells. Nonneutralized virus or virus incubated with b12 IgG (V / b12) or b12 Fab (V / Fab b12) were allowed to attach to cells at room temperature for 2 hr and then incubated at 35Њ for the times shown. Cells were inoculated with nonneutralized virus, incubated for 0, 3, or 6 hr at 35Њ, and immunostained with anti-p24 IgG (a-c respectively) or an anti-gp41 MAb after 6 hr at 35Њ (d). Other cells were inoculated with b12 IgG neutralized virus and incubated for 0, 3, or 6 hr at 35Њ and immunostained with anti-p24 (e-g, respectively), or with anti-gp41 (3 hr only shown, h). Still other cells were inoculated with b12 Fab-neutralized virus and incubated for 0, 3, or 6 hr at 35Њ and immunostained with anti-p24 (i-k, respectively),or with anti-gp41 (3 hr only shown, l); (m) and (n) are noninfected (n.i.) cell controls stained with anti-p24 and anti-gp41, respectively. B12 IgG and b12 Fab gave 99.6 and 99.3% neutralization, respectively. The bar represents 40 mm. gested that b12 Fab recognized different epitopes from paratope orientation (Thomas et al., 1985; Mosser et al., other anti-CD4 binding site antibodies and that b12 may 1989) . (An IgG molecule is unlikely to cross-link adjacent recognize a region proximal to or only partly overlapping envelope spikes of HIV-1 since their center-to-center disthe CD4 binding site.
tance is about 28-35 nm, given that the diameter of the Since b12 IgG and Fab neutralized without inhibiting virion is approximately 109 nm (Nermut et al., 1993 ) and attachment of virus to target cells, their effect on virion that there are about 75 envelope projections per virion entry into the cell, the next stage of infection, was deter- (Gelderblom et al., 1987) . The longest dimension of the mined by using several different techniques, including top surface of the gp120 oligomer is 15 nm (Gelderblom the ability of virions to fuse with the cell plasma memet al., 1987) , so that the distance between projections brane by fluorescence dequenching (Fig. 6) , virus-mediwill be approximately 13-20 nm, whereas the span of a ated cell-cell fusion (Fig. 7) , and direct visualization of human IgG1 molecule is approximately 9-15 nm (Valenvirion proteins by immunofluorescence (Fig. 8) . B12 IgG tine and Green, 1967; Werner et al., 1972 ; Gopalnakrishdid not inhibit attachment of virus to cells, as discussed nan and Karush, 1974)). Alternatively, b12 IgG may block above, but clearly inhibited the fluorescence dequenchfusion sterically, although b12 F(ab) 2 , derived by pepsin ing that indicates that virion-cell fusion has taken place digestion, neutralized and inhibited fusion as well as the (Fig. 6) . In corroboration of this, b12 IgG quantitatively IgG (data not shown). Thus any steric effect would be inhibited virus-mediated cell-cell fusion in direct proporfinely balanced as the F(ab) 2 and Fab have M r of about tion to the extent of neutralization (Fig. 7) . Immunofluores-100,000 and 50,000, respectively. It is interesting that b12 cence studies of the interaction of HIV-1 virions with IgG is one of three fusion-inhibiting MAbs that are able target cells, which have not been reported before, conto neutralize HIV-1 after it has attached to cells (Armfirmed all these observations (Fig. 8) . The failure of virion strong and Dimmock, 1996; data not shown). Other MAbs p24 of b12 IgG-neutralized virus to acquire resistance to are unable to do so at physiological temperature. removal with trypsin ( Fig. 9 ) also is quantitatively consisWe have concluded that b12 IgG neutralizes by inhibtent with inhibition of fusion entry by b12 IgG. Thus four iting virus-cell fusion while b12 Fab inhibits a postentry lines of evidence independently suggest that b12 IgG stage of infection. This raises the possibility that the IgG neutralizes HIV-1 by inhibiting the fusion entry process possesses both neutralizing activities and in effect kills into the target cell. However, the virus-cell interactions HIV-1 twice over. A similar inference was made about observed with b12 Fab-neutralized virus were profoundly an influenza A virus neutralizing antibody that inhibited different. In experiments conducted simultaneously, b12 the fusion entry process, when it was found that artifiFab had little effect on virus-cell fusion, on HIV-mediated cially fusing the virus with the cell using polyethylene cell-cell fusion, and in the immunofluorescence study glycol (PEG) did not reverse neutralization (Armstrong the patterns of p24 and gp41 staining were indistinguishand Dimmock, 1992) . Nonneutralized influenza virus beable from those of nonneutralized virus (Fig. 8) . In addicame fully infectious when treated with PEG. tion, Fig. 9 shows that the acquisition of resistance to The conclusion that neutralization by b12 Fab acts at removal by trypsin of virus attached to cells was unafa postfusion stage is intriguing. Details of the nature or fected by Fab neutralization. Together these data demontotal number of uncoating events undergone by the virion strate that b12 Fab neutralized HIV-1 without hindering are not known, but the subvirion particles undergo seveither the attachment or fusion entry processes. Thus eral complex stages of uncoating before the first macrowe conclude that b12 Fab neutralizes by inhibiting an molecular synthetic event by reverse transcriptase can event that occurs after entry of the virus core into the commence, and the mature preintegration complex is cell has taken place. What this event might be and why completed. These include uncoating of the MA (p17) it differs from the mechanism of neutralization of b12 IgG core, the CA (p24) nucleocapsid, and the ribonucleoprois discussed below.
tein, where uncoating involves physical removal from the The observation that an IgG and its Fab neutralize by virion core and phosphorylation reactions (Bukrinskaya different mechanisms has not been previously reported. et al., 1996; Gallay et al., 1996) , and possibly conformaThe difference in their mode of action may result from tional changes. B12 Fab probably acts indirectly since the ability of the IgG to attach bivalently to an envelope fusion of virus and cell plasma membrane leaves the protein and cross-link its constituent gp120 molecules.
Fab on the outside of the cell and the virion core on the This is likely to be intraoligomer crosslinking as envelope inside of the cell. It might prevent one of the postfusion proteins are calculated to be too far apart to permit inentry events from taking place or activate one of them terspike crosslinking unless the epitopes were at the at an inappropriate time or location. There are parallels periphery (see below). Such crosslinking might confer a with some influenza A mabs (reviewed in Dimmock, 1993, rigidity which abrogated fusion with the cell membrane.
1995). The mechanism(s) by which such neutralizing antiHowever, we have no evidence that this antibody actually bodies can affect postinternalization events remain(s) to attaches bivalently, and indeed some antibodies cannot bind bivalently to a single virion due to the epitopebe determined.
